Paraplatin 150 mg/15 ml
Paraplatin 150 mg/15 ml is a medicine authorised by Swissmedic under authorisation number 47671. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 August 1986 and the authorisation is valid without a time limit. ATC code L01XA02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 47671 |
|---|---|
| Name | Paraplatin 150 mg/15 ml |
| Full name | Paraplatin 150 mg/15 ml, Infusionslösung |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XA02 |
| First authorisation | 26 August 1986 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Paraplatin 150 mg/15 ml, Infusionslösung | A | 26 August 1986 |
| 2 | Paraplatin 450 mg/45 ml, Infusionslösung | A | 26 August 1986 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 51 | 1 x 150mg/15 ml | Durchstechflasche(n) | L01XA02 | 07.16.1. | A |
| 78 | 1 x 450mg/45ml | Durchstechflasche(n) | L01XA02 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Paraplatin 150 mg/15 ml authorised in Switzerland?
Yes. Paraplatin 150 mg/15 ml is authorised by Swissmedic under authorisation number 47671, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Paraplatin 150 mg/15 ml have?
Paraplatin 150 mg/15 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Paraplatin 150 mg/15 ml?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.